Ask Vendit Off-Topic Questions Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Ask Vendit Off-Topic Questions

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Walkingshadow who wrote (3849)	1/14/2005 9:14:09 PM
From: Vendit™	Read Replies (2) of 8752

TRIAL RESULTS Clinical Study Shows STARPHARMA’s VivaGel is Safe MELBOURNE, Australia, Dec. 16, 2004: Starpharma Holdings Limited (ASX:SPL) today released full human clinical trial results indicating that VivaGel™ (SPL7013 gel) has a suitable safety profile to be developed as a vaginal microbicide for the prevention of HIV. pharmalive.com This is very hard to find. I concur, the stock is not trading at this time.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next